APR 15, 2021 8:30 AM PDT

A Portable Ebola Detector, 1000x More Sensitive Than Lab-Based Tests

WRITTEN BY: Tara Fernandez


Duke University scientists have created a highly sensitive Ebola virus portable diagnostic device, 1000 times more sensitive than the current standard. The new test delivers the results a full day earlier than the polymerase chain reaction (PCR) test typically used in diagnostic labs.

The Ebola virus, first discovered in the 1970s, is transmitted through direct contact with the blood, body fluids, and tissues of infected people and animals. The virus is also known to persist in certain body fluids even after recovery from the illness.

According to Ebola experts, identifying infected patients early is critical for managing outbreaks. These individuals are highly contagious, so the earlier a positive diagnosis is made, the sooner the patient (and those they have had contact with) can be isolated. Additionally, early interventions can be life-saving—treating patients with antibody-based Ebola therapeutics sooner can slash the fatality rate from 90 to just 10 percent.

On a practical level, achieving more efficient diagnostic procedures in Ebola-prone areas has been a challenge: the PCR test requires specialized equipment and trained personnel to perform it, is expensive, and takes around a week. To address these issues, scientists have explored the possibility of using lateral flow type assays, similar to the principle that powers over-the-counter pregnancy tests. While these check the boxes of cost-effectiveness and speed, they are considerably less sensitive. This means those in the earlier phases of infection can get a false negative readout.

Now, researchers are tapping into the best of both worlds, merging the advantages of PCR and lateral flow assays to create the D4 assay. This test quickly and accurately detects a protein produced by the virus early on during infection called the secreted glycoprotein, or sGP.

“Prior studies suggested that Ebola virus produces secreted glycoprotein at high levels early in infection to act as a decoy and distract the immune system while the virus replicates and binds to the host cells,”  said Cassio Fontes, one of the engineers who worked on the project. 

“We thought that if we could detect that, we could help facilitate earlier diagnosis, containment, and treatment during [an] Ebola outbreak.”

The D4 works using a hand-held detector called the D4Scope, which is powered by batteries and uses off-the-shelf components that can be replaced easily in the field. A drop of blood from the patient is applied to the chip (roughly half the size of a credit card), and any sGPs in the sample bind to antibodies on the device, emitting a fluorescent glow.

This has been a significant breakthrough in the field of Ebola diagnostics, says Fontes: “We’ve put the lateral flow assay to shame, sensitivity wise.”

“This is exciting because by understanding the biology of this virus, we’ve shown that there may be a target to look for where immunoassays like the D4 can outperform the PCR. It’s really breaking new ground.” 

 

 

Sources: Science Translational Medicine, Global Biodefense


 

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
DEC 29, 2020
Cardiology
Does Physical Activity Help Reduce the Risk of Aneurysms?
DEC 29, 2020
Does Physical Activity Help Reduce the Risk of Aneurysms?
An active lifestyle is a proven way to prevent many types of cardiovascular diseases. The increased blood flow can preve ...
DEC 30, 2020
Neuroscience
Brain Imaging Predicts Risk of PTSD
DEC 30, 2020
Brain Imaging Predicts Risk of PTSD
Until now, why posttraumatic stress disorder (PTSD) develops in some and not others following a physical and/ or psychol ...
FEB 01, 2021
Genetics & Genomics
As Many as 20% of Patients Would Benefit From Pharmacogenetic Testing
FEB 01, 2021
As Many as 20% of Patients Would Benefit From Pharmacogenetic Testing
Researchers have suggested that a simple genetic test could be a huge benefit to public health; it could tell clinicians ...
APR 05, 2021
Clinical & Molecular DX
COVID Variants Can't Hide From CRISPR Diagnostic
APR 05, 2021
COVID Variants Can't Hide From CRISPR Diagnostic
New variants of the coronaviruses have emerged over the course of the pandemic through the natural evolutionary process ...
APR 22, 2021
Clinical & Molecular DX
Gum Disease Makes COVID Patients More Likely to Die
APR 22, 2021
Gum Disease Makes COVID Patients More Likely to Die
Gum disease is associated with an increased risk of COVID-related ICU admission and death, says a study by McGill Univer ...
APR 21, 2021
Clinical & Molecular DX
Miniature Implant Checks Oxygen Levels in Internal Organs
APR 21, 2021
Miniature Implant Checks Oxygen Levels in Internal Organs
  Berkeley researchers have created the next generation of deep tissue oxygen sensors: A tiny, wireless device that ...
Loading Comments...